FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...
Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).
An advancement in diabetes treatment has been achieved by Professor Hyun-Wook Kang and his team from the Department of ...
Prediabetes is almost always a precursor to type 2 diabetes — but it doesn’t have to lead to that outcome. Experts share healthy steps to reverse the condition.
Global diabetes rates have surged, particularly in low-resource areas, revealing critical gaps in treatment access and ...
Fourteen percent of the world's people -- more than 800 million -- now have diabetes, a doubling of the global rate for the ...
Related Study finds fatty liver disease affects 4 in 10 U.S. adults Diabetes, kidney woes can lead to heart disease after ...
Diabetes is a metabolic disorder where the body either does not produce enough insulin or cannot effectively use the insulin ...
And while we may have to face these seasonal illnesses, we can support our immune health to help us stay ... The “Panax” in ...
Diabetes was the eighth-leading cause of death in the United States in 2021, and while the cure doesn't come in a magic pill, ...
Funding has been awarded to a University of Oxford project looking to develop a cure for type 1 diabetes ... in the development of type 1 diabetes and can cause transplanted beta cells to fail.